P1182 What has changed in Inflammatory Bowel Disease during last three decades?

S Altın,G Kemeç,K Kayıkçı,D Deniz,A O Çelik,Z İstemihan,K Nuriyev,A Rüstamzade,S Genç,B Cavus,A Çifcibaşı Örmeci,F Akyüz,K Demir,F Beşışık,S Kaymakoğlu

DOI: https://doi.org/10.1093/ecco-jcc/jjad212.1312

2024-01-01

Journal of Crohn's and Colitis

Abstract:Abstract Background With its increasing incidence, IBD varies epidemiologically both over the years and geographically. The increase in treatment alternatives over the years has led to differences in the management of patients. Revealing the impact of years on IBD from past to present and realizing the paths we have gone through will make us more conscious of future paths. Therefore, we aimed to reveal the epidemiological findings in our IBD patients over three decades. Methods IBD patients followed up at our university hospital, a tertiary center, were included in our study. The demographic, epidemiological and medical data of the patients were recorded retrospectively from the patient files. Descriptive statistics for continuous variables in the study; expressed as mean, standard deviation (SD), number (n) and percentage (%). "Independent T-test" and "One-Way Analysis of Variance (ANOVA)" were calculated to compare continuous measurements according to categorical groups. In the calculations, the statistical significance level was taken as p<0.05 and SPSS (IBM SPSS for Windows, ver.26) statistical package program was used for analyses. Results A total of 346 IBD patients, 198 of whom (57.2%) had Crohn's disease and were followed up from the gastroenterology outpatient clinic, were included in the study. The mean age of the patients was 49.07±13.82 years and the mean BMI was 23.02±4.58 kg/m2. 182 (52.6%) of the patients were male. The disease duration was 34.46±12.74 years. The patients were divided into three-decade groups according to their diagnosis dates as years: a total of 84 patients was diagnosed in 1985-2003, 192 patients in 2004-2013, and 70 patients in 2014-2023. The patients were compared within these date groups in terms of age at diagnosis, gender, first biological agent preference, and the time when the first biological agent was started (Fig.1). From the first decade to the third decade, the proportion of patients diagnosed with Crohn's disease was 50%, 57.3%, 65.7%, respectively, and the proportion of patients diagnosed with UC was 50%, 42.7% and 34.3%, respectively (p<0.05). The rates of requiring hospitalization at initial diagnosis were 48%, 42.2%, and 40%, respectively, from the first decade to the third decade (p<0.05). The need for bowel surgery at diagnosis (for Crohn's disease patients) was 33.3%, 26.36% and 13.04% within 3 decades, respectively (p<0.05). Conclusion While the rate of patients diagnosed with Crohn's disease has increased compared to 30 years ago, the rate of patients diagnosed with UC was decreased. While the need for hospitalization at diagnosis and the need for surgery in CD have decreased in the last decade compared, biological agents have been started earlier in IBD patients in the last decade.

gastroenterology & hepatology